TrialInternational journal of cancer2022

Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.

Julia C F Quintanilha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.